References and Notes
- 1
Galipeau J.
Benaim E.
Spencer HT.
Blakely R.
Sorrentino BP.
Hum.
Gene Ther.
1997,
8:
1773
- 2
Cavazzano-Valco M.
Hacien-Bey S.
Saint-Basile G.
Gross F.
Yvon E.
Nusbaum P.
Selz F.
Hue C.
Certain S.
Casanova JL.
Bousso P.
Deist F.
Fischer A.
Science
2000,
288:
669
- 3
Lehrman S.
Nature
(London)
1999,
401:
517
- 4
Marshall M.
Science
1999,
286:
2244
- 5 inventors; WO 2008/1368 A2. Hadasit Medical Research Services
and Development Ltd., State of Israel, Ministry of Agriculture and
Rural Development, Agricultural Research Organization
- 6
Bragadin M.
Dell’Antone P.
Arch. Environ.
Contam. Toxicol.
1996,
30:
280
- 7 Mitragotri S, Karande P, and Jain AK. inventors; US
2009/105260 A1.
- 8 Millikin C, Goodman L, Bissett D, Robinson L, and Osborne R. inventors; US
2008/206373 A1.
- 9 inventors; WO 2008/64976 A1. Unilever PLC, Unilever NV, Hindustan
Unilever Limited;
- 10 Mitra S. inventors; US
2008/95731 A1.
- 11 Millikin C, Bissett D, and Clear R. inventors; US
2008/69784 A1.
- 12
Nicholas GM.
Li R.
MacMillan JB.
Molinski TF.
Bioorg. Med. Chem.
Lett.
2002,
12:
2159
- 13 inventors; Accentia Inc. WO 2008/8494 A2.
- 14 inventors; Veckis Industries
Ltd. WO 2005/44287 A1.
- 15
Pasquale E.
Anchez P.
Fantini J.
Maresca M.
Smail C.
Brunel J.
Chem. Phys. Lipids
2010,
163:
131
- 16
Massi L.
Guittard F.
Géribaldi S.
Levy R.
Eur. J. Med. Chem.
2009,
1615
- 17
Rajakumar P.
Sekar K.
Shanmugaiah V.
Mathivanan N.
Bioorg. Med. Chem. Lett.
2008,
18:
4416
- 18
Thorsteinsson T.
Masson M.
Kristinsson KG.
Hjalmarsdottir MA.
Hilmarsson H.
Loftsson T.
J. Med. Chem.
2003,
46:
4173
- 19
Choubey V.
Maity P.
Guha M.
Kumar S.
Srivastava K.
Puri SK.
Bandyopadhyay U.
Antimicrob.
Agents Chemother.
2007,
51:
696
- 20
Ancelin ML.
Galas M.
Bonhoure A.
Herbute S.
Vial HJ.
Antimicrob.
Agents Chemother.
2003,
47:
2598
- 21
Lukac M.
Valentova J.
Lacko I.
Devinsky F.
Karlovska J.
Mojzis J.
Mojzisova G.
Mrva M.
Ondriska F.
Bukovsky M.
Eur. J. Med. Chem.
2009,
4970
- 22
Mével M.
Montier T.
Lamarche F.
Delépine P.
Le Gall T.
Yaouanc J.-J.
Jaffrès P.-A.
Cartier D.
Lehn P.
Clément J.-C.
Bioconjugate
Chem.
2007,
18:
1604
- 23
Mukherjee K.
Bhattacharyya J.
Sen J.
Sistla R.
Chaudhuri A.
J.
Med. Chem.
2008,
51:
1967
- 24
Faraldos JA.
Coates RM.
O’Maille PE.
Dellas N.
Noel JP.
J. Am. Chem. Soc.
2010,
132:
4281
- 25
Ravikumar PC.
Yao L.
Fleming F.
J.
Org. Chem.
2009,
74:
7294
- 26
Kelly BD.
Lambert TH.
J. Am. Chem. Soc.
2009,
131:
13930
- 27
Dubey A.
Upadhyay AK.
Kumar P.
Tetrahedron
Lett.
2010,
51:
744
- 28
Saikia D.
Parihar S.
Chanda D.
Ojha S.
Kumar JK.
Chanotiya CS.
Shanker K.
Negi AS.
Bioorg. Med. Chem. Lett.
2010,
20:
508
- 29
Hebting Y.
Adam P.
Albrecht P.
Org.
Lett.
2003,
5:
1571
- 30
Majeti BK.
Karmali PP.
Reddy BS.
Chaudhuri A.
J.
Med. Chem.
2005,
48:
3784
- 31
Takeo T.
Phytochemistry
1981,
20:
2149
- 32
Ecroyd CE.
Franich RA.
Kroese HW.
Steward D.
Phytochemistry
1995,
40:
1387
- 33
Dunphy PJ.
Phytochemistry
2006,
67:
1110
- 34
Bates RB.
Gale DM.
Gruner BJ.
J.
Org. Chem.
1963,
28:
1086
- 35
Vasquez M.
Quijano L.
Urbatsch LE.
Fischer NH.
Phytochemistry
1992,
31:
2051
- 36
Karrer P.
Salomon H.
Fritzsche H.
Helv.
Chim. Acta
1937,
20:
1422
- 37
Drewes SE.
Khan F.
Vuuren S.
Viljoen AM.
Phytochemistry
2005,
66:
1812
- 38
Ioannou E.
Zervou M.
Ismail A.
Ktari L.
Vagias C.
Roussis V.
Tetrahedron
2009,
66:
10565
- 41
Lee S.
Peterson CJ.
Coats JR.
J.
Stored Prod. Res.
2003,
39:
77
- 42
Hammer KA.
Carson CF.
Riley TV.
J. Appl. Microbiol.
2003,
95:
853
- 43
Friedman M.
Henika PR.
Mandrell RE.
J. Food Prot.
2002,
65:
1545
- 44
Frank T.
Bieri K.
Speiser B.
Ann.
Appl. Biol.
2002,
141:
93
- 45
Szczepanik M.
Dams I.
Wawrzenczyk C.
Environ. Entomol.
2005,
34:
1433
- 46
Vourc’h G.
J.
Chem. Ecol.
2002,
28:
2411
- 47
Eymery F.
Iorga B.
Savignac P.
Tetrahedron
1999,
55:
13109
- 48
Gilman H.
Gaj BJ.
J. Am. Chem. Soc.
1960,
82:
6326
- 49
Smrt J.
Catlin J.
Tetrahedron Lett.
1970,
11:
5081
39
Representative
Procedure for the Preparation of
N
,
N
,
N
-Triethyltridecan-1-aminium Chloride (2a)
A solution of 1a (5.0
g, 25.0 mmol) in CH2Cl2 (10 mL) and Et3N
(10 mL) was added dropwise to a stirred solution of POCl3 (7.6
g, 50.0 mmol) in dichloromethane (10 mL) at 0 ˚C. After
stirring the solution for 1 h, a solution of N,N-diethylethanolamine (4.4 g, 37.5 mmol)
in Et3N (10 mL) was added. The whole reaction mixture
was stirred for 1 h at 0 ˚C followed by 2 h at r.t. Water
(5 mL) was added dropwise to the reaction mixture and stirred for
additional 30 min. Then, 10 mL of 10% solution of citric
acid and MeOH-H2O (1:1) was added to the reaction
mixture and extracted into CHCl3 (3 × 100
mL). The combined organic layer was washed with MeOH-H2O
(1:1) and dried over anhyd Na2SO4. The solvent
was evaporated under reduced pressure, and the crude product was
chromatographed on silica gel as stationary phase and CHCl3-MeOH-H2O
(91.5:8:0.5) as mobile phase to afford the compound 2a (4.26
g, 60%). ¹H NMR (300 MHz, CDCl3): δ = 3.60-3.03
(m, 8 H), 1.43 (m, 2 H), 1.18-1.04 (m, 29 H), 0.70 (t, J = 6.2 Hz,
3 H). ¹³C NMR (50 MHz, CDCl3): δ = 57.6,
53.6 (3 C), 32.2, 30.0 (6 C), 29.8, 29.7, 29.5, 26.8, 26.1, 23.0,
22.2, 14.4. ESI-MS:
m/z = 284.4.
40
Representative
Procedure for the Preparation of 1-Nonylpyridinium Chloride (2f)
A solution of 1f (5 g, 26.9 mmol) in CH2Cl2 (10
mL) and pyridine (10 mL) was added dropwise to the stirred solution of
POCl3 (8.25 g, 53.7 mmol) in CH2Cl2 (10
mL) at 0 ˚C. After stirring for 1 h, a solution of N,N-diethylethanolamine (4.7
g, 40.3 mmol) in pyridine (10 mL) was then added at 0 ˚C.
The whole reaction mixture was stirred for 1 h at 0 ˚C followed
by 2 h at r.t. Water (5 mL) was added dropwise to the reaction mixture
and stirred for additional 30 min. Then, 10 mL of 10% solution
of citric acid and MeOH-H2O (1:1) was added
in the reaction mixture and extracted into CHCl3 (2 × 100
mL). The combined organic layer was washed with MeOH-H2O
(1:1) and dried over anhyd Na2SO4. The solvent
was evaporated under reduced pressure, and the crude product was
chromatographed on silica gel as stationary phase and CHCl3-MeOH-H2O
(89.5:10:0.5) as mobile phase to afford the compound 2f (3.67
g, 55%). ¹H NMR (200 MHz, CD3OD): δ = 9.04
(d, J = 5.8
Hz, 2 H), 8.61 (t, J = 7.7
Hz, 1 H), 8.13 (t, J = 6.9
Hz, 2 H), 4.66 (t, J = 7.6
Hz, 2 H), 2.03 (t, J = 6.9
Hz, 2 H), 1.38-1.28 (m, 18 H), 0.89 (t, J = 6.7
Hz, 3 H). ¹³C NMR (50 MHz, CD3OD): δ = 145.9,
145.0 (2 C), 128.6 (2 C), 62.2, 32.1, 31.5, 29.7 (2 C), 29.6, 29.5,
29.1, 26.2, 22.7, 13.5. ESI-MS: m/z = 248.3.